Find Federal Grants

Status

Agency

Office of Postsecondary Education (OPE): Student Support Service: Gaining Early Awareness and Readiness for Undergraduate Programs (GEAR UP) Partnership Grants, Assistance Listing Number 84.334A

★ Save Archived

Department of Education · ED-GRANTS-112024-001

Closes: Feb 3, 2025 Up to: $5,000,000 Program funding: $35,000,000

Biology of Bladder Cancer (R01 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · PAR-25-129

Closes: Sep 7, 2025

Biology of Bladder Cancer (R21 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · PAR-25-128

Closes: Sep 7, 2025 Up to: $200,000 Program funding: $200,000

Advancing Genomic Medicine Research (R21 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-HG-25-003

Closes: Feb 11, 2025 Up to: $250,000

Advancing Genomic Medicine Research (R01 Clinical Trial Optional)

★ Save Archived

National Institutes of Health · RFA-HG-25-002

Closes: Feb 11, 2025

Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

★ Save Archived

National Institutes of Health · PAR-25-275

Closes: Feb 28, 2025

FY 2025 U.S. Study Abroad Engagement Grants

★ Save Archived

U.S. Mission to Namibia · WHK-STUDYABROAD-FY25-02

Closes: Dec 13, 2024 Up to: $15,000 Program funding: $15,000

NCMRR Early Career Research Award (R03 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-124

Closes: Jan 7, 2028 Up to: $200,000 Program funding: $200,000

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

★ Save Posted

National Institutes of Health · PAR-25-096

Closes: Nov 17, 2026 Up to: $200,000 Program funding: $200,000

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-25-095

Closes: Nov 6, 2026 Up to: $350,000 Program funding: $350,000

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-25-070

Closes: Jan 7, 2027

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

★ Save Posted

National Institutes of Health · PAR-25-069

Closes: Jan 7, 2027

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-25-229

Closes: Sep 7, 2027

Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-25-228

Closes: Sep 7, 2027

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-25-244

Closes: Nov 16, 2027

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

★ Save Posted

National Institutes of Health · PAR-25-243

Closes: Jan 7, 2028

Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)

★ Save Archived

National Institutes of Health · PA-25-174

Closes: May 7, 2025

Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)

★ Save Archived

National Institutes of Health · PA-25-173

Closes: May 7, 2025

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

★ Save Closed

National Institutes of Health · PAR-25-111

Closes: Jul 6, 2026

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

★ Save Closed

National Institutes of Health · PAR-25-110

Closes: Jul 7, 2026